Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

124.84
Delayed Data
As of Aug 24
 -4.80 / -3.70%
Today’s Change
97.52
Today|||52-Week Range
164.04
-20.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues386.2M404.9M369.0M412.6M
 
 
 
 
 
Cost of Goods Sold2.8M17.3M700.0K12.1M
 
 
 
 
 
Depreciation And Amortization8.2M8.0M--7.9M
 
 
 
 
 
Operating ExpensesGross Income375.2M379.6M368.3M392.6M
 
 
 
 
 
General Expenses-11.9M224.5M4.6M107.4M
 
 
 
 
 
Research And Development5.4M75.9M-400.0K35.2M
 
 
 
 
 
Total Operating Expenses-858.0K249.8M5.3M127.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income387.1M155.1M363.7M285.2M
 
 
 
 
 
Interest Expense On Debt834.0K546.0K600.0K600.0K
 
 
 
 
 
Other Expenses350.6M1.5M800.0K1.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income736.9M156.0M363.9M285.7M
 
 
 
 
 
Income Taxes-272.4M-51.4M-128.4M-79.6M
 
 
 
 
 
Net Income464.4M104.6M235.5M206.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS45.5M45.7M45.4M44.3M
 
 
 
 
 
Shares To Calculate EPS Diluted50.2M49.7M48.7M46.9M
 
 
 
 
 
 
Earnings Per ShareEPS$9.24$2.10$4.84$4.39
 
 
 
 
 
EPS Diluted$9.24$2.10$4.84$4.39